Liver pathology in Wilson's disease: From copper overload to cirrhosis

被引:57
|
作者
Gerosa, C. [1 ]
Fanni, D. [1 ]
Congiu, T. [1 ]
Piras, M. [1 ]
Cau, F. [2 ]
Moi, M. [1 ]
Faa, G. [1 ]
机构
[1] Univ Cagliari AOU Cagliari, Div Pathol, Cagliari, Italy
[2] San Gavino Hosp, ATS, Div Pathol, San Gavino, Italy
关键词
METAL-BINDING DOMAINS; TRANSPORTER ATP7B; EXPRESSION; DIAGNOSIS; ZINC; LOCALIZATION; STEATOSIS; MUTATIONS; INSIGHTS; THERAPY;
D O I
10.1016/j.jinorgbio.2019.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wilson's disease (WD) is a genetic metabolic disease strictly associated with liver cirrhosis. In this review, the genetic bases of the disease are discussed, with emphasis on the role of ATP7B (the Wilson disease protein) dysfunction as a determinant factor of systemic copper overload. Regarding the different multiple mutations described in WD patients, the peculiarity of Sardinian population is highlighted, Sardinians carrying a rare deletion in the promoter (5' UTR) of the WD gene. The role of epigenetic changes in the clinical presentation and evolution of liver disease in WD patients is also discussed, nutrition probably representing a relevantly risk factor in WD patients. The role of transmission electron microscopy in the diagnosis of WD-related liver disease is underlined. Mitochondrial changes, increased peroxisomes fat droplets, lipolysosomes and intranuclear glycogen inclusions are reported as the most frequent ultrastructural changes in the liver of WD carriers. The role of histochemical stains for copper is analyzed, and the Timm's method is suggested as the most sensitive one for revealing hepatic copper overload in all stage of WD. The marked variability of the histological liver changes occurring in WD is underlined simple steatosis may represent the only pathological changes, frequently associated with glycogenated nuclei. Mallory-Denk bodies lipogranulomas alcoholic and non-alcoholic fatty liver disease ending with bridging fibrosis and cirrhosis. Finally, the reversal of fibrosis as a possible therapeutic objective in WD is discussed.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 50 条
  • [41] Is liver copper quantitation mandatory to exclude Wilson disease?
    Gow, PJ
    Angus, PW
    Smith, AL
    Wall, AJ
    Smallwood, RA
    Sewell, RB
    GASTROENTEROLOGY, 1998, 114 (04) : A1248 - A1248
  • [42] Encephalopathy in Wilson Disease: Copper Toxicity or Liver Failure?
    Ferenci, Peter
    Litwin, Tomasz
    Seniow, Joanna
    Czlonkowska, Anna
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 : S88 - S95
  • [43] Honeycomb liver in Wilson's disease
    Ethiraj, D.
    Indiran, V.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (09) : 684 - 684
  • [44] Liver transplantation for Wilson's disease
    Schilsky, Michael L.
    HUMAN DISORDERS OF COPPER METABOLISM II, 2014, 1315 : 45 - 49
  • [45] Elastography of the Liver in Wilson's Disease
    Nehring, Piotr
    Szeligowska, Jowita
    Przybylkowski, Adam
    DIAGNOSTICS, 2023, 13 (11)
  • [46] Liver transplantation for Wilson's disease
    Semis, S.
    Karakayali, H.
    Aliosmanoglu, I.
    Yilmaz, U.
    Ozcay, F.
    Torgay, A.
    Arslan, G.
    Haberal, M.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (01) : 228 - 230
  • [47] HFE genotyping in children with Wilson's disease and iron overload
    Polyakova, S., I
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 157 - 157
  • [48] Recovery from severe neurological Wilson's disease with copper chelation
    Aggarwal, A.
    Bhatt, M.
    MOVEMENT DISORDERS, 2012, 27 : S71 - S71
  • [49] Neonatal Liver Cirrhosis Without Iron Overload Caused by Gestational Alloimmune Liver Disease
    Debray, Francois-Guillaume
    de Halleux, Virginie
    Guidi, Ornella
    Detrembleur, Nancy
    Gaillez, Stephanie
    Rausin, Leon
    Goyens, Philippe
    Pan, Xiaomin
    Whitington, Peter F.
    PEDIATRICS, 2012, 129 (04) : E1076 - E1079
  • [50] Dietary copper restriction in Wilson’s disease
    Kylie Russell
    Lyn K. Gillanders
    David W. Orr
    Lindsay D. Plank
    European Journal of Clinical Nutrition, 2018, 72 : 326 - 331